Sector › Medicine
Press Releases
Sirnaomics will present clinical study results and development strategy for Cancer RNA Therapeutics at the 2022 Pre-ASCO China Summit
Sirnaomics Ltd.
May 20, 2022 11:10 HKT/SGT
Fujitsu and RIKEN start joint research on next-generation IT drug discovery technology using the supercomputer Fugaku and simulation integrated AI
Fujitsu Ltd
May 17, 2022 10:32 HKT/SGT
노보텍, 프리-ASCO중국 서밋 후원: 초기 단계 종양학 임상에 기반해 진행 여부 결정
Novotech Health Holdings Pte Ltd
May 12, 2022 21:00 HKT/SGT
Elevating Australia's Scientific Acumen: Large Molecule Facility Doubles Size of Australia's Top Bioanalytical Laboratory
Agilex Biolabs
May 12, 2022 16:00 JST
Elevating Australia's Scientific Acumen: Large Molecule Facility Doubles Size of Australia's Top Bioanalytical Laboratory
Agilex Biolabs
May 12, 2022 15:00 HKT/SGT
Q&M Dental net profit, excluding other gains or losses, increased by 25% to S$7.2 million on S$46.8 million of revenue for quarter ended 31 March 2022
Q&M Dental Group Ltd
May 12, 2022 09:00 HKT/SGT
Novotech Sponsors Pre-ASCO China Summit: Go/No Go Decisions Based on Early Phase Oncology Trials
Novotech Health Holdings Pte Ltd
May 12, 2022 06:00 HKT/SGT
Novotech 赞助 ASCO 中国峰会前夕：基于早期肿瘤学试验的 Go/No Go 决策
Novotech Health Holdings Pte Ltd
May 12, 2022 06:00 HKT/SGT
Novotech 贊助 ASCO 中國峰會前夕：基於早期腫瘤學試驗的 Go/No Go 決策
Novotech Health Holdings Pte Ltd
May 12, 2022 06:00 HKT/SGT
Sirnaomics to Present Latest Developments on its GalNAc-Based Liver-Targeting Platforms and GalAhead(TM) Programs at the TIDES USA 2022
Sirnaomics Ltd.
May 11, 2022 14:33 HKT/SGT
Hitachi High-Tech and Invivoscribe Partner to Advance Molecular Diagnostics
Hitachi, Ltd.
May 10, 2022 14:18 HKT/SGT
エーザイ、抗アミロイドβ（Aβ）プロトフィブリル抗体「レカネマブ」について、米国において、迅速承認制度に基づく早期アルツハイマー病に対する生物製剤ライセンス申請の段階的申請を完了
Eisai
May 10, 2022 11:00 JST
エーザイ、筋萎縮性側索硬化症（ALS）に対する高用量メコバラミン製剤の医師主導治験の結果を踏まえて、日本における新薬承認申請に向けた作業を開始
Eisai
May 10, 2022 11:00 JST